Fundamentals Hub
BFNH BIOFORCE NANOSCIENCES HOLDINGS, INC.
BFNH financial statements, revenue, balance sheet, cash flow, and SEC filings
Showing 3 of 9 annual and 0 of 35 quarterly periods.
Full history available with a free account or via API.
▼ Company Profile
Filer Category
<br>Emerging growth company
Entity Type
Operating
Public Float
$2.63M (Jun 2025)
Industry (SIC)
3826 Laboratory Analytical Instruments
Fiscal Year End
December (1231)
Phone
757-306-6090
EIN
852138858
Headquarters
VIRGINIA BEACH, VA, 23454
Public Float History
Market value of shares held by public investors, reported in annual DEI filings.
Former Names:
SILVER RIVER VENTURES, INC. (2004–2006)
▼ Key Metrics (TTM)
As of Jun 30, 2026Financials
Revenue
-
Net Income
$-97.44K
Total Assets
$2.39M
Total Equity
$2.30M
Total Debt
-
Free Cash Flow
-
Ratios
Return on Equity
-4.2%
Return on Assets
-4.1%
Current Ratio
25.41x
Sources and calculation details
Reported values are preserved. Derived values use the listed inputs; unavailable inputs remain blank.
Field-level sources for this historical record are unavailable until it is rebuilt from SEC facts.
Annual (FY)
Quarterly 🔒
Chart 🔒
| Metric | FY2025 📄 | FY2024 📄 | FY2023 📄 |
|---|---|---|---|
| Income Statement | |||
| REVENUE | |||
| OPERATING EXPENSES | |||
| SG&A Expense | $66.95K | $67.44K | $48.95K |
| NON-OPERATING INCOME / EXPENSE | |||
| Pretax Income | $-489.95K | $-490.44K | - |
| Net Income | $-1.29M | $-490.44K | $-471.95K |
| PER SHARE & SUPPLEMENTAL | |||
| Diluted EPS | $-0.04 | $-0.02 | $-0.02 |
| Diluted Shares | 33.21M | 29.27M | 29.27M |
| Balance Sheet | |||
| ASSETS | |||
| Cash & Equivalents | $786 | $862 | $638 |
| Current Assets | $786 | $862 | $638 |
| Noncurrent Assets | $0 | $0 | $0 |
| Total Assets | $786 | $862 | $638 |
| LIABILITIES | |||
| Accounts Payable | $11.84K | $8.84K | $2.65K |
| Current Liabilities | $619.33K | $2.30M | $1.82M |
| Noncurrent Liabilities | $0 | $0 | $0 |
| Total Liabilities | $619.33K | $2.30M | $1.82M |
| EQUITY | |||
| Common Stock | $33.52K | $29.27K | $29.27K |
| Additional Paid-in Capital | $161.76M | $158.79M | $158.78M |
| Retained Earnings | $-162.41M | $-161.12M | $-160.63M |
| Total Equity | $-618.54K | $-2.30M | $-1.82M |
| Total Liabilities & Equity | $786 | $862 | $638 |
| SUPPLEMENTAL | |||
| Shares Outstanding | 33.52M | 29.27M | 29.27M |
| Check: A − (L + E + NCI) | - | - | - |
| Cash Flow Statement | |||
| Cash from Operations | $-65.15K | $-61.25K | $-46.70K |
| Capital Expenditures | - | - | - |
| Cash from Investing | - | - | - |
| Cash from Financing | $65.07K | $61.47K | $46.61K |
| Free Cash Flow | - | - | - |
| Beginning Cash (CFS) | $862 | $638 | - |
| Net Change in Cash | - | - | - |
| Effect of FX on Cash | - | - | - |
| Calculated Ending Cash | - | - | - |
| Cash per BS | $786 | $862 | $638 |
| Cash scope difference (CFS − BS) | - | - | - |
| Cash per CFS | $786 | $862 | $638 |
Create a free account to see full history, quarterly data, charts, CSV downloads, and API access.
Create Free Account Log In🔒
Quarterly data and charts require a free account
Get access to 8 quarters of data, interactive charts, CSV downloads, and API access.
▼ Frequently Asked Questions
Is BIOFORCE NANOSCIENCES HOLDINGS, INC. profitable?
No. BIOFORCE NANOSCIENCES HOLDINGS, INC. reported $-97.44K in net income for trailing twelve months. Profitability data is based on the company's most recent annual report filed with the SEC.